Completed
A Study of Tirzepatide (LY3298176) Versus Insulin Degludec in Participants With Type 2 Diabetes
I8F-MC-GPGH - ClinicalTrials.gov - NCT03882970
The purpose of this study is to compare the effect of the study drug tirzepatide to insulin degludec on blood sugar levels in participants with type 2 diabetes.
How long will I be in the trial?
The study will last about 59 weeks and may include up to 22 visits.
Completed
A Study of Tirzepatide (LY3298176) Versus Insulin Degludec in Participants With Type 2 Diabetes
I8F-MC-GPGH - ClinicalTrials.gov - NCT03882970
The purpose of this study is to compare the effect of the study drug tirzepatide to insulin degludec on blood sugar levels in participants with type 2 diabetes.
How long will I be in the trial?
The study will last about 59 weeks and may include up to 22 visits.
Key Requirements
Age :
18+
Sex:
All
Key Requirements
Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.
Age
18+
Sex
All
Participants must
Participant must have type 2 diabetes mellitus (T2DM)
Participant must be on stable treatment dose of metformin, with or without an SGLT-2 inhibitor
Participant must be of stable weight
Participants must NOT
Participant must not have type 1 diabetes mellitus (T1DM)
Participant must not have pancreatitis
Participant must not have disorders with slowed emptying of the stomach contents, or have had any stomach surgeries for the purpose of weight loss
Participant must not have acute or chronic hepatitis or symptoms of any other liver disease
Participant must not have had a heart attack stroke, or hospitalization for congestive heart failure in the past 2 months
Participant must not have been taking weight loss drugs including over-the-counter medications during the last 3 months
Trial Summary
Conditions the trial is for
Adult Type 2 Diabetes
What the trial is testing?
Tirzepatide, Insulin Degludec
Could I receive a Placebo?
no
Enrollment Goal
1420
Trial Dates
April 2019 - January 2021
Trial Phase
3
Enter your postal code to find the nearest site
Key Requirements
Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.
Age
18+
Sex
All
Participants must
Participant must have type 2 diabetes mellitus (T2DM)
Participant must be on stable treatment dose of metformin, with or without an SGLT-2 inhibitor
Participant must be of stable weight
Participants must NOT
Participant must not have type 1 diabetes mellitus (T1DM)
Participant must not have pancreatitis
Participant must not have disorders with slowed emptying of the stomach contents, or have had any stomach surgeries for the purpose of weight loss
Participant must not have acute or chronic hepatitis or symptoms of any other liver disease
Participant must not have had a heart attack stroke, or hospitalization for congestive heart failure in the past 2 months
Participant must not have been taking weight loss drugs including over-the-counter medications during the last 3 months
Trial Summary
Conditions the trial is for
Adult Type 2 Diabetes
What the trial is testing?
Tirzepatide, Insulin Degludec
Could I receive a Placebo?
no
Enrollment Goal
1420
Trial Dates
April 2019 - January 2021
Trial Phase
3
Not the right fit? Sign up to receive updates on new trials.
Trial Locations
Hide locations not currently recruiting
Enter your postal code to see sites near you
Adult Type 2 Diabetes Resources
